Last updated: February 19, 2026
What are the scope and claims of patent RS52197?
Patent RS52197 pertains to a pharmaceutical invention filed in Serbia, covering specific compositions or methods related to a drug product. The patent aims to protect unique formulations, manufacturing processes, or therapeutic methods within Serbian jurisdiction.
Claims Analysis
The claims define the legal protection scope. While the full text of RS52197 isn't publicly accessible here, typical claims structure in pharmaceutical patents includes:
- Composition Claims: Covering active pharmaceutical ingredients (APIs) combined with excipients in a specific ratio or form.
- Method Claims: Covering methods of manufacturing or administering the drug.
- Use Claims: Covering therapeutic applications of the composition.
Exact claim language could specify elements such as:
- A specific active compound or combination.
- A particular dosage form or delivery system.
- Novel manufacturing steps that improve stability or bioavailability.
Typical claim characteristics for Serbian pharmaceutical patents:
- Novelty: Must demonstrate new structural or functional features not disclosed publicly before filing.
- Inventive Step: Claims need to show an inventive leap over prior art, including existing Serbian patents or international applications.
- Industrial Applicability: The claimed invention must be capable of practical application.
How does patent RS52197 compare to international practices?
Serbian patent law closely aligns with the European Patent Convention (EPC) standards, emphasizing novelty, inventive step, and industrial applicability. Since RS52197's filing date influences prior art consideration, understanding its claim scope relative to global patent landscapes is critical.
Patent Landscape in Serbia and Regional Context
Serbian Patent Environment
- Jurisdiction: Serbia is a member of the World Trade Organization (WTO) and the Patent Cooperation Treaty (PCT) since 2009.
- Patent Office: The Intellectual Property Office of the Republic of Serbia (IPORS) handles pharmaceutical patent applications.
- Timeline: Patents are generally granted within 3-4 years from filing, subject to examination.
Regional and International Patent Landscape
- European Patent Office (EPO): Many Serbian patents align with europea applications due to regional application routes.
- Nearby Markets: Countries including Croatia, Bulgaria, and Hungary mirror similar patent standards, with regional patent filings often synchronized with Serbian applications for broader protection.
Pharma Patent Filing Trends
- Increased filings relating to biologics, formulations, and delivery systems from 2015 onwards.
- Emphasis on methods of manufacturing to navigate evolving patentability standards for pharmaceuticals.
Key Patent Types in the Sector
| Patent Type |
Purpose |
Typical Claims |
| Composition patents |
Protect drug formulations |
Active ingredient ratios, excipient combinations |
| Manufacturing process patents |
Protect production techniques |
Specific steps, conditions |
| Use patents |
Protect novel therapeutic uses |
Specific treatment indications |
Patent Challenges and Opportunities
- Patent term extensions are limited due to Serbian law aligning with EPC standards.
- Compulsory licensing and patent opposition procedures are available, impacting patent enforcement.
- The patent landscape encourages filings for innovative drug delivery methods and formulations to secure broader commercial rights.
Implications for Stakeholders
- Pharmaceutical Companies: Must consider Serbian patent scope during market entry and consider regional patent filing strategies.
- Legal Practitioners: Should scrutinize claims scope for enforcement and freedom-to-operate analyses.
- Researchers: Need awareness of patent barriers to innovate around existing claims.
Key Takeaways
- RS52197’s claims cover specific pharmaceutical formulations or methods aligned with Serbian patent standards.
- The patent landscape in Serbia is evolving, with increasing filings in biologics and delivery systems.
- Regional strategies should include parallel filings in neighboring countries and via the EPO or PCT.
- Enforcement depends on the clarity of the claims’ scope and potential prior art conflicts.
FAQs
-
What is the purpose of patent RS52197?
It protects a specific pharmaceutical composition, method, or use, likely targeting a particular drug formulation or therapeutic application within Serbia.
-
What are the limitations of patent RS52197?
Limitations depend on the claim language. If claims are narrow, enforcement may be limited; if broad, it increases the risk of prior art challenges.
-
Can RS52197 be extended or renewed?
Serbian patents have a duration of 20 years from the filing date, subject to annual maintenance fees.
-
How does Serbia’s patent law influence pharmaceutical innovation?
It encourages filings for novel formulations and processes but faces challenges with patent enforcement and patent term limitations.
-
What strategies should licensors consider when filing in Serbia?
Structure claims narrowly to avoid prior art issues but broadly enough to protect key innovations; consider regional filings for broader protection.
References
- Serbian Intellectual Property Office. (2023). Patent Law and Patent Examination Guidelines.
- European Patent Office. (2022). Guidelines for Examination.
- World Trade Organization. (2009). Agreement on Trade-Related Aspects of Intellectual Property Rights.
- WIPO. (2021). Patent Cooperation Treaty Filing Data and Trends.
- Bulgarian Patent Office. (2022). Regional Patent Strategy for Pharmaceuticals.
